Total planned funding: $132,475,789
Clear active filters
HTXD: Treatment: ARV Drugs
University
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $107,234,873 |
| South Africa | $10,205,764 |
| Uganda | $9,036,542 |
| Asia Regional Program | $3,019,936 |
| Kenya | $2,560,000 |
| Cameroon | $125,038 |
| Botswana | $100,587 |
| Tanzania | $100,000 |
| Ethiopia | $60,000 |
| Western Hemisphere Region | $33,049 |
| Ukraine | $0 |
| Eswatini | $0 |
| Rwanda | $0 |
| Zimbabwe | $0 |
| Lesotho | $0 |
| Democratic Republic of the Congo | $0 |
| Zambia | $0 |
| Côte d'Ivoire | $0 |
| Namibia | $0 |
| Haiti | $0 |
| South Sudan | $0 |
| Mozambique | $0 |
| Vietnam | $0 |
| Burundi | $0 |
| Malawi | $0 |
Organizational Types
| University | $132,475,789 |
Program Areas
| Treatment | $132,475,789 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $132,475,789 |
Top Partner Programs
Harvard University:
$43,588,613
View countries
University of Maryland:
$42,305,645
View countries
Columbia University:
$27,614,711
View countries
Baylor College of Medicine:
$7,720,496
View countries
University of KwaZulu-Natal:
$5,391,173
View countries